The correlation of lactate/albumin ratio and their association for short-term and long-term mortality in patients with acute aortic dissection

乳酸/白蛋白比值的相关性及其与急性主动脉夹层患者短期和长期死亡率的关系

阅读:1

Abstract

OBJECTIVE: The direct impact on survival of lactate-to-albumin ratio (LAR) in acute aortic dissection (AAD) remains uncertain. METHODS: Medical electric records of 919 patients in the intensive care unit (ICU) who diagnosed with AAD were extracted from the MIMIC-IV database. These patients were subsequently divided into quartiles according to their LAR. Multivariable Cox regression incorporating restricted cubic spline terms was applied to examine how LAR relates to all-cause death at 30-, 90-, and 365-day intervals after ICU admission. To probe possible nonlinearities, we used smoothed curve analyses and fitted segmented (2-piece) linear models where appropriate. RESULTS: Kaplan-Meier curves showed progressively poorer survival among patients in the highest LAR quartile. Multivariable Cox proportional-hazards analysis shown the greatest quartile exhibited adjusted hazard ratios of 1.329 (95% confidence interval [CI], 1.118-1.579) at 30 days, 1.314 (95% CI, 1.130-1.527) at 90 days and 1.263 (95% CI, 1.096-1.455) at 365 days compared with the lowest quartile. Restricted cubic spline modeling revealed a positive association between increasing LAR and mortality risk in critically ill patients with AAD. Consistent patterns emerged across all clinically relevant subgroups. Smooth-curve fitting suggested a nonlinear relationship between LAR and mortality risk; subsequent piecewise linear regression identified inflection points for all-cause death at 30, 90, and 365 days of 0.769, 0.385, and 0.381, respectively. CONCLUSIONS: Even after multivariable adjustment, the LAR demonstrated a robust association with all-cause mortality at 30, 90, and 365 days in patients with AAD in the ICU.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。